McCulloch Scott D, Kunkel Thomas A
Laboratory of Molecular Genetics and Laboratory of Structural Biology, National Institute of Environmental Health Sciences, NIH, DHHS, Research Triangle Park, NC 27709, United States.
DNA Repair (Amst). 2006 Nov 8;5(11):1373-83. doi: 10.1016/j.dnarep.2006.06.003. Epub 2006 Jul 28.
We hypothesize that enzymatic switching during translesion synthesis (TLS) to relieve stalled replication forks occurs during transitions from preferential to disfavored use of damaged primer-templates, and that the polymerase or 3'-exonuclease used for each successive nucleotide incorporated is the one whose properties result in the highest efficiency and the highest fidelity of bypass. Testing this hypothesis requires quantitative determination of the relative lesion bypass ability of both TLS polymerases and major replicative polymerases. As a model of the latter, here we measure the efficiency and fidelity of cis-syn TT dimer and abasic site bypass using the structurally well-characterized T7 DNA polymerase. No bypass of either lesion occurred during a single round of synthesis, and the exonuclease activity of wild-type T7 DNA polymerase was critical in preventing TLS. When repetitive cycling of the exonuclease-deficient enzyme was allowed, limited bypass did occur but hundreds to thousands of cycles were required to achieve even a single bypass event. Analysis of TLS fidelity indicated that these rare bypass events involved rearrangements of the template and primer strands, insertions opposite the lesion, and combinations of these events, with the choice among these strongly depending on the sequence context of the lesion. Moreover, the presence of a lesion affected the fidelity of copying adjacent undamaged template bases, even when lesion bypass itself was correct. The results also indicate that a TT dimer presents a different type of block to the polymerase than an abasic site, even though both lesions are extremely potent blocks to processive synthesis. The approaches used here to quantify the efficiency and fidelity of TLS can be applied to other polymerase-lesion combinations, to provide guidance as to which of many possible polymerases is most likely to bypass various lesions in biological contexts.
我们推测,在跨损伤合成(TLS)过程中,当从优先使用受损引物模板转变为不优先使用时,会发生酶促转换以缓解停滞的复制叉,并且用于掺入每个连续核苷酸的聚合酶或3'-外切核酸酶是其特性导致最高效率和最高保真度绕过的酶。检验这一假设需要定量测定TLS聚合酶和主要复制聚合酶的相对损伤绕过能力。作为后者的模型,我们在此使用结构特征明确的T7 DNA聚合酶测量顺式-顺式TT二聚体和无碱基位点绕过的效率和保真度。在一轮合成过程中,两种损伤均未发生绕过,野生型T7 DNA聚合酶的外切核酸酶活性对于防止TLS至关重要。当允许对缺乏外切核酸酶的酶进行重复循环时,确实发生了有限的绕过,但即使实现单个绕过事件也需要数百至数千个循环。TLS保真度分析表明,这些罕见的绕过事件涉及模板链和引物链的重排、损伤对面的插入以及这些事件的组合,在这些事件之间的选择强烈取决于损伤的序列背景。此外,即使损伤绕过本身是正确的,损伤的存在也会影响相邻未受损模板碱基复制的保真度。结果还表明,TT二聚体对聚合酶呈现出与无碱基位点不同类型的障碍,尽管这两种损伤对连续合成都是极其有效的障碍。此处用于量化TLS效率和保真度的方法可应用于其他聚合酶-损伤组合,以指导在生物学背景下众多可能的聚合酶中哪一种最有可能绕过各种损伤。